Thyroid-stimulating immunoglobulin levels during low-dose antithyroid therapy predict Graves’ disease relapse [PDF]
BackgroundGraves’ disease (GD) is a common autoimmune disorder often treated with antithyroid drugs (ATD), but relapse rates remain high after therapy withdrawal.
Phong Vu Nhat Nguyen, Khue Thy Nguyen
doaj +2 more sources
Clinical relevance of thyroid-stimulating immunoglobulin as a biomarker of the activity of thyroid eye disease. [PDF]
Jeon H, Lee JY, Kim YJ, Lee MJ.
europepmc +3 more sources
Elevated Graves' Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis. [PDF]
Alvin Mathew A +4 more
europepmc +3 more sources
Thyroid-stimulating immunoglobulins in neonatal Graves's disease. [PDF]
Two patients with neonatal Graves's disease are reported. One of them had a delayed onset because of suppression of the fetal thyroid gland by antithyroid drug taken by the mother during pregnancy. Thyroid-stimulating immunoglobulins (TSAb), measured by a receptor assay, were present in both babies when they were thyrotoxic, and also in their mothers ...
C.S. Teng +3 more
openalex +4 more sources
Thyroid Stimulating Immunoglobulin Measurement [PDF]
National Cancer Institute
openalex +2 more sources
Graves' disease (GD) is a common autoimmune disorder that causes an excess of thyroid hormone production. It is mainly due to the production of IgG antibodies that activate the thyrotropin receptor.
Alkhansaa Tariq +2 more
doaj +2 more sources
A study of thyroid-stimulating immunoglobulins in thyroid diseases
published_or_final_version ; Medicine ; Master ; Doctor of ...
Chong-shing Teng
openalex +3 more sources
Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy. [PDF]
Khamisi S +5 more
europepmc +3 more sources
The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease [PDF]
Han-Sang Baek +2 more
exaly +2 more sources

